BNIP3 is inactivated by methylation of the CpG island at the transcriptional start site in gastric, pancreatic, and colorectal cancer [38], and methylase inhibitor 5-aza deoxycytidine can restore the deficiency. This evidence concerns the gene BNIP3 and colorectal cancer.